No Data
No Data
B.Riley Financial Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $10
ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024
ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) P/S Is Still On The Mark Following 33% Share Price Bounce
Strength Seen in ClearPoint Neuro (CLPT): Can Its 16.9% Jump Turn Into More Strength?
Clinical Laserthermia Systems Gets Additional SEK7.5 Million Orders From ClearPoint Neuro
Express News | Aspen Neuroscience Uses MRI-Guided ClearPoint Navigation System For Patients Enrolled In ASPIRO Phase 1/2a Clinical Trial For Transplantation Of Dopaminergic Neuron Precursor Cells In Patients With Parkinson's Disease
No Data